title: 3,4-Dihydro-2H-benzoxazinones as dual-acting 5-HT1A receptor antagonists and serotonin reuptake inhibitors.
abstract: Investigation of halogen substitution in lead compound 1 has led to the identification of analogues which combine high affinity for 5-HT(1A) receptors and potent serotonin reuptake inhibitory activity. Several compounds show an improved selectivity over 5-HT(1B) and 5-HT(1D) receptors and a superior pharmacokinetic profile in the rat.
authors.affiliation: Psychiatry Centre of Excellence for Drug Discovery, GlaxoSmithKline, New Frontiers Science Park, Third Avenue, Harlow, Essex CM19 5AW, UK. Peter.J.Lovell@gsk.com
authors.forename: Peter J
authors.initials: PJ
authors.lastname: Lovell
authors.forename: Frank E
authors.initials: FE
authors.lastname: Blaney
authors.forename: Caroline J
authors.initials: CJ
authors.lastname: Goodacre
authors.forename: Claire M
authors.initials: CM
authors.lastname: Scott
authors.forename: Paul W
authors.initials: PW
authors.lastname: Smith
authors.forename: Kathryn R
authors.initials: KR
authors.lastname: Starr
authors.forename: Kevin M
authors.initials: KM
authors.lastname: Thewlis
authors.forename: Antonio K K
authors.initials: AK
authors.lastname: Vong
authors.forename: Simon E
authors.initials: SE
authors.lastname: Ward
authors.forename: Jeannette M
authors.initials: JM
authors.lastname: Watson
mesh_terms: D000818:Animals; D048588:Benzoxazines / Q000138:chemical synthesis* / Q000494:pharmacology*; D001667:Binding, Competitive / Q000187:drug effects; D016466:CHO Cells; D002144:Callithrix; D002460:Cell Line; D002540:Cerebral Cortex / Q000187:drug effects / Q000378:metabolism; D006224:Cricetinae; D003412:Cricetulus; D006168:Guinea Pigs; D006801:Humans; D007202:Indicators and Reagents; D009682:Magnetic Resonance Spectroscopy; D013058:Mass Spectrometry; D008958:Models, Molecular; D010879:Piperazines / Q000494:pharmacology; D011725:Pyridines / Q000494:pharmacology; D011869:Radioligand Assay; D051381:Rats; D044282:Receptor, Serotonin, 5-HT1A / Q000187:drug effects*; D044302:Receptor, Serotonin, 5-HT1B / Q000187:drug effects; D044346:Receptor, Serotonin, 5-HT1D / Q000187:drug effects; D012702:Serotonin Antagonists / Q000138:chemical synthesis* / Q000494:pharmacology*; D017367:Selective Serotonin Reuptake Inhibitors / Q000138:chemical synthesis* / Q000494:pharmacology*; D013574:Synaptosomes / Q000187:drug effects
chemical_list: D048588:Benzoxazines; D007202:Indicators and Reagents; D010879:Piperazines; D011725:Pyridines; D044282:Receptor, Serotonin, 5-HT1A; D044302:Receptor, Serotonin, 5-HT1B; D044346:Receptor, Serotonin, 5-HT1D; D012702:Serotonin Antagonists; D017367:Selective Serotonin Reuptake Inhibitors; C090413:N-(2-(4-(2-methoxyphenyl)-1-piperazinyl)ethyl)-N-(2-pyridinyl)cyclohexanecarboxamide